The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent ...

The final composition of Andy Farrell’s British and Irish Lions squad to tour Australia is likely to come down to his view of ...

If you're concerned about having enough money for retirement, building a plan for yourself is important -- especially in ...